Recombinant CCN2 (Pamrevlumab Biosimilar) antibody

Catalog No. ABIN7538068

This anti-CCN2 (Pamrevlumab Biosimilar) antibody is a Human Monoclonal antibody detecting CCN2 (Pamrevlumab Biosimilar) in ELISA and WB. Suitable for Human.

Quick Overview for Recombinant CCN2 (Pamrevlumab Biosimilar) antibody (ABIN7538068)

Target: CCN2 (Pamrevlumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CCN2 (Pamrevlumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-CCN2 (Pamrevlumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Pamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CCN2 (Pamrevlumab Biosimilar)

Target: CCN2 (Pamrevlumab Biosimilar)

Background: Pamrevlumab is a recombinant human antibody that binds to connective tissue growth factor (CTGF). It can be used for the research of idiopathic pulmonary fibrosis (IPF).

CAS-No: 946415-13-0